OA10713A - Benzopyran and related ltb4 antagonists - Google Patents
Benzopyran and related ltb4 antagonists Download PDFInfo
- Publication number
- OA10713A OA10713A OA60544A OA60544A OA10713A OA 10713 A OA10713 A OA 10713A OA 60544 A OA60544 A OA 60544A OA 60544 A OA60544 A OA 60544A OA 10713 A OA10713 A OA 10713A
- Authority
- OA
- OAPI
- Prior art keywords
- alkyl
- hydrogen
- phenyl
- compound
- formula
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/08—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing alicyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
- C07C255/11—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms containing cyano groups and singly-bound oxygen atoms bound to the same saturated acyclic carbon skeleton
- C07C255/13—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms containing cyano groups and singly-bound oxygen atoms bound to the same saturated acyclic carbon skeleton containing cyano groups and etherified hydroxy groups bound to the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/45—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by condensation
- C07C45/46—Friedel-Crafts reactions
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups
- C07C59/64—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Transplantation (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pulmonology (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyrane Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US82467892A | 1992-01-23 | 1992-01-23 | |
| US89005592A | 1992-05-28 | 1992-05-28 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| OA10713A true OA10713A (en) | 2002-12-04 |
Family
ID=27124835
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| OA60544A OA10713A (en) | 1992-01-23 | 1994-07-22 | Benzopyran and related ltb4 antagonists |
Country Status (27)
| Country | Link |
|---|---|
| US (1) | US5550152A (is) |
| EP (1) | EP0623122B1 (is) |
| JP (1) | JP2813464B2 (is) |
| KR (1) | KR950700274A (is) |
| CN (1) | CN1074681A (is) |
| AP (1) | AP385A (is) |
| AT (1) | ATE149493T1 (is) |
| AU (1) | AU2773392A (is) |
| BG (1) | BG98873A (is) |
| BR (1) | BR9207064A (is) |
| CA (1) | CA2117349C (is) |
| CZ (1) | CZ395492A3 (is) |
| DE (1) | DE69217998T2 (is) |
| DK (1) | DK0623122T3 (is) |
| ES (1) | ES2098547T3 (is) |
| FI (1) | FI943473A0 (is) |
| GR (1) | GR3022999T3 (is) |
| HU (1) | HUT67929A (is) |
| IL (1) | IL104421A0 (is) |
| IS (1) | IS3968A (is) |
| MX (1) | MX9300313A (is) |
| NO (1) | NO942758D0 (is) |
| OA (1) | OA10713A (is) |
| PT (1) | PT101182A (is) |
| TW (1) | TW213456B (is) |
| UY (1) | UY23537A1 (is) |
| WO (1) | WO1993015066A1 (is) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX9300312A (es) * | 1992-01-23 | 1993-07-31 | Pfizer | Antagonistas benzopiranicos y relacionado de ltb. |
| HUT77515A (hu) * | 1994-10-13 | 1998-05-28 | Pfizer Inc. | Hidrogénezett benzopirán- és naftalinszármazékok, ezeket tartalmazó gyógyszerkészítmények és intermedierjeik |
| US5939452A (en) * | 1994-10-13 | 1999-08-17 | Pfizer Inc | Benzopyran and benzo-fused compounds, their preparation and their use as leukotriene B4' (LTB4) antagonists |
| BR9711482A (pt) * | 1996-09-16 | 1999-08-24 | Pfizer | Processos e intermedi rios para a prepara-Æo de derivados de cromanol substitu¡dos |
| US6416733B1 (en) | 1996-10-07 | 2002-07-09 | Bristol-Myers Squibb Pharma Company | Radiopharmaceuticals for imaging infection and inflammation |
| EP0836850A3 (en) * | 1996-10-17 | 2000-11-29 | Pfizer Inc. | Method of preventing allograft rejection |
| EP0963755A3 (en) * | 1998-04-16 | 2001-03-14 | Pfizer Products Inc. | Use of benzopyranes for preventing allograft rejection |
| EP1347784A2 (en) | 2000-11-03 | 2003-10-01 | Bristol-Myers Squibb Pharma Company | Simultaneous dual isotope imaging of cardiac perfusion and cardiac inflammation |
| US6541613B2 (en) * | 2000-12-15 | 2003-04-01 | Uyrex Corporation | Isoflavone derivatives |
| US6958156B2 (en) * | 2000-12-15 | 2005-10-25 | Vyrex Corporation | Isoflavone derivatives |
| WO2002060888A1 (en) * | 2001-01-30 | 2002-08-08 | Pfizer Products Inc. | Processes for preparing chromanylbenzoic acids |
| RU2007101510A (ru) * | 2004-07-22 | 2008-08-27 | Фармаци Корпорейшн (US) | Композиции для лечения воспаления и боли с использованием комбинации селективного ингибитора сох-2 и антагониста рецептора ltb4 |
| JP4977760B2 (ja) * | 2006-10-31 | 2012-07-18 | ファイザー・プロダクツ・インク | 鉱質コルチコイド受容体拮抗薬としてのピラゾリン化合物 |
| CN104710438B (zh) * | 2013-12-11 | 2019-11-29 | 中国科学院上海药物研究所 | 促进iPS细胞产生的螺环类化合物及其制备方法和用途 |
| US10849954B2 (en) * | 2014-11-11 | 2020-12-01 | Juntendo Educational Foundation | Preventive or therapeutic agent for age-related macular degeneration |
| AR105911A1 (es) | 2015-09-03 | 2017-11-22 | Forma Therapeutics Inc | Inhibidores de hdac8 bicíclicos fusionados [6,6] |
| EP3383869B1 (en) | 2015-11-30 | 2023-06-28 | Merck Sharp & Dohme LLC | Aryl sulfonamides as blt1 antagonists |
| EP3383388B1 (en) | 2015-11-30 | 2021-04-14 | Merck Sharp & Dohme Corp. | Aryl acylsulfonamides as blt1 antagonists |
| EP3383868B1 (en) | 2015-11-30 | 2022-10-05 | Merck Sharp & Dohme LLC | Aryl sulfonamides as blt1 antagonists |
| US10370368B2 (en) | 2015-11-30 | 2019-08-06 | Merck Sharp & Dohme Corp. | Aryl acylsulfonamides as BLT1 antagonists |
| CN109289091B (zh) * | 2018-10-09 | 2021-04-13 | 温州医科大学附属第一医院 | 一种用于装载骨髓间充质干细胞的复合支架及其制备方法 |
| CN111647003B (zh) * | 2020-06-08 | 2022-06-21 | 中国科学院昆明植物研究所 | 三环氧六氢色酮a及其药物组合物和其应用 |
| CN111671745A (zh) * | 2020-07-29 | 2020-09-18 | 北京大学 | 化合物在治疗溃疡性结肠炎药物制备中的应用 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4565882A (en) * | 1984-01-06 | 1986-01-21 | G. D. Searle & Co. | Substituted dihydrobenzopyran-2-carboxylates |
| CA1320490C (en) * | 1987-01-12 | 1993-07-20 | Darrel M. Gapinski | Anti-inflammatory agents |
| US4889871A (en) * | 1987-05-29 | 1989-12-26 | G. D. Searle & Co. | Alkoxy-substituted dihydrobenzopyran-2-carboxylate derivatives |
| US5059609A (en) * | 1987-10-19 | 1991-10-22 | Pfizer Inc. | Substituted tetralins, chromans and related compounds in the treatment of asthma, arthritis and related diseases |
| WO1990015801A1 (en) * | 1989-06-22 | 1990-12-27 | Pfizer Inc. | Substituted sulfonamides and related compounds in the treatment of asthma, arthritis and related diseases |
-
1992
- 1992-10-13 EP EP92921463A patent/EP0623122B1/en not_active Expired - Lifetime
- 1992-10-13 DE DE69217998T patent/DE69217998T2/de not_active Expired - Lifetime
- 1992-10-13 ES ES92921463T patent/ES2098547T3/es not_active Expired - Lifetime
- 1992-10-13 BR BR9207064A patent/BR9207064A/pt not_active Application Discontinuation
- 1992-10-13 CZ CS923954A patent/CZ395492A3/cs unknown
- 1992-10-13 US US08/256,809 patent/US5550152A/en not_active Expired - Lifetime
- 1992-10-13 JP JP5513182A patent/JP2813464B2/ja not_active Expired - Fee Related
- 1992-10-13 CA CA002117349A patent/CA2117349C/en not_active Expired - Lifetime
- 1992-10-13 AU AU27733/92A patent/AU2773392A/en not_active Abandoned
- 1992-10-13 DK DK92921463.3T patent/DK0623122T3/da active
- 1992-10-13 HU HU9402163A patent/HUT67929A/hu unknown
- 1992-10-13 WO PCT/US1992/008555 patent/WO1993015066A1/en active IP Right Grant
- 1992-10-13 AT AT92921463T patent/ATE149493T1/de not_active IP Right Cessation
- 1992-10-17 TW TW081108272A patent/TW213456B/zh active
- 1992-11-10 AP APAP/P/1992/000441A patent/AP385A/en active
-
1993
- 1993-01-18 IL IL104421A patent/IL104421A0/xx unknown
- 1993-01-18 UY UY23537A patent/UY23537A1/es unknown
- 1993-01-19 IS IS3968A patent/IS3968A/is unknown
- 1993-01-20 CN CN93100695A patent/CN1074681A/zh active Pending
- 1993-01-22 PT PT101182A patent/PT101182A/pt not_active Application Discontinuation
- 1993-01-22 MX MX9300313A patent/MX9300313A/es unknown
-
1994
- 1994-06-24 BG BG98873A patent/BG98873A/xx unknown
- 1994-07-22 NO NO942758A patent/NO942758D0/no unknown
- 1994-07-22 FI FI943473A patent/FI943473A0/fi unknown
- 1994-07-22 OA OA60544A patent/OA10713A/en unknown
- 1994-07-23 KR KR1019940702540A patent/KR950700274A/ko not_active Application Discontinuation
-
1997
- 1997-04-01 GR GR970400673T patent/GR3022999T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| FI943473A (fi) | 1994-07-22 |
| TW213456B (is) | 1993-09-21 |
| PT101182A (pt) | 1994-03-31 |
| WO1993015066A1 (en) | 1993-08-05 |
| AP9200441A0 (en) | 1993-01-31 |
| CA2117349C (en) | 2000-02-29 |
| DE69217998D1 (de) | 1997-04-10 |
| UY23537A1 (es) | 1993-06-28 |
| DE69217998T2 (de) | 1997-06-12 |
| CZ395492A3 (en) | 1994-03-16 |
| EP0623122B1 (en) | 1997-03-05 |
| MX9300313A (es) | 1994-06-30 |
| ES2098547T3 (es) | 1997-05-01 |
| HU9402163D0 (en) | 1994-09-28 |
| FI943473A0 (fi) | 1994-07-22 |
| GR3022999T3 (en) | 1997-07-30 |
| ATE149493T1 (de) | 1997-03-15 |
| CN1074681A (zh) | 1993-07-28 |
| NO942758L (no) | 1994-07-22 |
| BR9207064A (pt) | 1995-12-19 |
| HUT67929A (en) | 1995-05-29 |
| AU2773392A (en) | 1993-09-01 |
| EP0623122A1 (en) | 1994-11-09 |
| IL104421A0 (en) | 1993-05-13 |
| US5550152A (en) | 1996-08-27 |
| BG98873A (en) | 1995-03-31 |
| DK0623122T3 (da) | 1997-04-21 |
| IS3968A (is) | 1993-07-24 |
| JPH07503464A (ja) | 1995-04-13 |
| JP2813464B2 (ja) | 1998-10-22 |
| NO942758D0 (no) | 1994-07-22 |
| CA2117349A1 (en) | 1993-08-05 |
| KR950700274A (ko) | 1995-01-16 |
| AP385A (en) | 1995-05-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| OA10713A (en) | Benzopyran and related ltb4 antagonists | |
| CA2438961C (en) | Beta-lactam compounds, manufacturing methods of the compounds and serum hypocholesterolemic agents containing the compounds | |
| US6133286A (en) | Tetrahydronaphthalene and tetrahydroquinoline compounds, their preparation and their use as leukotriene B4 (LTB4) antagonists | |
| IL98191A (en) | A process for the enantioselective preparation of phenylisosarine history | |
| HU194858B (en) | Process for producing dibenzo/b,d/pirane derivatives and pharmaceutical compositions containing them | |
| US5684046A (en) | Hydrogenated naphthalenes and related LTB4 antagonists | |
| KR20090105309A (ko) | 광학활성을 갖는 5-히드록시-3-옥소헵타노에이트 유도체의제조방법 | |
| US6441173B1 (en) | Process for preparing indane carboxylate and cyclopentano [6] pyridine derivatives | |
| US5001255A (en) | Idene analogs of mevalonolactone and derivatives thereof | |
| US4851440A (en) | Leukotriene antagonists, processes for the preparation thereof, the use thereof for the treatment of diseases, and precursors | |
| KR860000299B1 (ko) | 2-히드록시-4-(치환)페닐시클로알칸류와 그 유도체 및 중간체의 제조 방법 | |
| US5461156A (en) | Stereocontrolled synthesis of cis-bicyclic compounds | |
| JP3097678B2 (ja) | アファノルフィン中間体 | |
| US5079349A (en) | Trimethylsilyl acetylene compounds, their preparation and their use in the preparation of daunomycinone derivatives | |
| JPS62178581A (ja) | ハロクロマン類 | |
| JPH0427980B2 (is) | ||
| Wang et al. | An efficient synthesis of an optically active (-)-(3R, 4R, 5R)-4-(1-hydroxyl-isopropyl)-3-acetyloxyl-butyrolactone | |
| JP2002114749A (ja) | 光学活性２−ヒドロキシ−３−フェニルプロピオニトリル誘導体の製造法 | |
| EP0524190A1 (en) | Hmg-co a reductive inhibitors | |
| JPS61280469A (ja) | 新規なβ−ラクタム化合物 | |
| WO1994006746A1 (en) | 6-heptynoic and heptenoic acid compounds | |
| JPH04283530A (ja) | ４−置換−２−メチル−１，２−ブタンジオール誘導体の製造方法 | |
| JPH11255687A (ja) | １，１′，５′，１″−テルナフタレン−２，２′，６′，２″−テトラオール | |
| JPS61291538A (ja) | ２−ハロ−４−ヒドロキシ−２−シクロペンテノン類 |